IR is considered a core causal factor of hyper- tension, obesity, coronary artery disease, dyslipidemia, and metabolic syndrome [2] and is therefore actively studied worldwide. IR can result from various genetic or acquired causes, in- cluding obesity, body fat distribution,...
These metabolites in turn activate various signaling cascades that interfere with insulin signaling and β-cell function, further contributing to the gluco/lipotoxicity.4 Obesity also increases cardiovascular risk factors, such as dyslipidemia, hypertension and atherosclerosis. Therefore much of the research...
(2021). https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(21)00251-5/fulltext The role of specific components of a plant-based diet in management of dyslipidemia and the impact on cardiovascular risk. Nutrients. (2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551487/...
Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32:1263–82. PubMed Google Scholar Larsson SC, Orsini N. Red meat and processed meat consumption and all-cause mortality: a meta-analysis....
The global prevalence of NAFLD is approximately 25 % [5], and is quickly increasing, mirroring the worldwide rise in obesity and its associated complications [6]. Approximately 80 % of subjects with NAFLD are obese and have dyslipidemia, ~70 % have hypertension, and ~50 % have type 2 diab...
With this in mind, let’s look at some of the potential causes of elevated LDL particle number. If your LDL-P is high, it makes sense to test for and treat any of the conditions below (with the exception of the last, which is genetic and thus can’t be treated) before—or at lea...
It is also similar to how, if measures to treat metabolic syndrome pay off, then high blood pressure, diabetes, and dyslipidemia will also tend to improve. Those initiatives are not exactly simple, but they will still hold great importance if undertaken. Within Japan, developments following the...
The planning of a clinical trial depends on the question that the investigator is addressing. The general objective is usually obvious, but the specific question to be answered by the trial is often not stated well. Stating the question clearly and in ad
various signaling cascades that interfere with insulin signaling and β-cell function, further contributing to the gluco/lipotoxicity.4Obesity also increases cardiovascular risk factors, such as dyslipidemia, hypertension and atherosclerosis. Therefore much of the research efforts over the past two decades...
These metabolites in turn activate various signaling cascades that interfere with insulin signaling and β-cell function, further contributing to the gluco/lipotoxicity.4 Obesity also increases cardiovascular risk factors, such as dyslipidemia, hypertension and atherosclerosis. Therefore much of the research...